CoChat

Behavioral and Pharmacological Studies on Gluten Exorphin A5, a Newly Isolated Bioactive Food Protein Fragment, in Mice

Open access
Takahashi, Masakatsu, Fukunaga, Hiroko, Kaneto, Hiroshi, Fukudome, Shin-ichi, Yoshikawa, Masaaki · 2000 · Japanese Journal of Pharmacology
Cited by 75

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Central effects of gluten exorphin A5 (Gly-Tyr-Tyr-Pro-Thr), a fragment from wheat gluten, were studied on the pain-inhibitory system, emotionality and learning/memory processes in mice. Orally administered gluten exorphin A5 produced neither an antinociceptive effect nor an effect on morphine analgesia. Intracerebroventricularly (i.c.v.) administered gluten exorphin A5 produced mild but significant antinociception in a dose-depepndent manner, while not affecting the morphine analgesia. On the other hand, oral gluten exorphin A5 suppressed the endogenous pain-inhibitory system, i.e., antinociception induced by socio-psychological- (PSY-) stress (SIA) using a communication box; intraperitoneal gluten exorphin A5 abolished both footshock- (FS-) stress-induced antinociception (SIA) and PSY-SIA; and i.c.v. gluten exorphin A5 suppressed FS-SIA, but rather potentiated PSY-SIA. This peptide given by these routes was without effect on forced swim-SIA. In addition, oral gluten exorphin A5 tended to prolong the retention time on open arms in the elevated plus-maze test. Finally, oral gluten exorphin A5 when given during the post-training period of learning/memory processes significantly increased the latency into the dark compartment in the one-trail step-though type passive avoidance test, indicating that the peptide also facilitates the acquire/consolidation process of learning/memory. Thus, gluten exorphin A5 has been found to produce various effects not only in the peripheral nervous systems but also in the central nervous system.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1254/jjp.84.259

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 32

  1. Fujita, 1996, Vasorelaxation by casomokinin L, a derivative of β-casomorphin and casoxin D, is mediated by NK1 receptor, Peptides, 17, 635, 10.1016/0196-9781(96)00067-8 · DOI
  2. Brantl, 1979, A material with opioid activity in bovine milk and milk products, Naunyn Schmiedebergs Arch Pharmacol, 306, 301, 10.1007/BF00507118 · DOI
  3. Zioudrou, 1979, Opioid peptides derived from food proteins. The exorphins, J Biol Chem, 254, 2446, 10.1016/S0021-9258(17)30243-0 · DOI · Paper page
  4. Yoshikawa, 1984, Opioid peptides from human β-casein, Agric Biol Chem, 48, 3185, 10.1271/bbb1961.48.3185 · DOI · Paper page
  5. Brantl, 1985, Novel opioid peptides derived from mitochondrial cytochrome b: cytochrophins, Eur J Pharmacol, 111, 293, 10.1016/0014-2999(85)90773-3 · DOI
  6. Brand, 1986, Novel opioid peptides derived from hemoglobin: hemorphins, Eur J Pharmacol, 125, 309, 10.1016/0014-2999(86)90044-0 · DOI · Paper page
  7. Yoshikawa, 1986, Opioid peptides from milk proteins, Agric Biol Chem, 50, 2419, 10.1080/00021369.1986.10867763 · DOI
  8. Chiba, 1989, Opioid antagonist peptides derived from kappa-casein, J Dairy Res, 56, 363, 10.1017/S0022029900028818 · DOI · Paper page
  9. Tani, 1990, Isolation and characterization of opioid antagonist peptides derived from human lactoferrin, Agric Biol Chem, 54, 1803
  10. Takahashi, 1998, Albutensin A, an ileum-contracting peptide derived from serum albumin, acts through both receptors for complements C3a and C5a, Lett Peptide Sci, 5, 29, 10.1007/BF02443537 · DOI
  11. Fujita, 1995, Isolation and characterization of ovokinin, a bradykinin Bl agonist peptide derived from ovalbumin, Peptides, 16, 785, 10.1016/0196-9781(95)00054-N · DOI
  12. Maruyama, 1985, Angiotensin I-converting enzyme inhibitor derived from an enzymatic hydrolysate of casein. II. Isolation and bradykinin-potentiating activity on the uterus and the ileums of rats, Agric Biol Chem, 49, 1405
  13. Kohama, 1988, Isolation of angiotensin-converting enzyme inhibitor from tuna muscle, Biochem Biophys Res Commun, 155, 332, 10.1016/S0006-291X(88)81089-1 · DOI · Paper page
  14. Yokoyama, 1992, Peptide inhibitors for angiotensin I-converting enzyme from thermolysin digest of dried bonito, Biosci Biotechnol Biochem, 56, 1541, 10.1271/bbb.56.1541 · DOI · Paper page
  15. Jolles, 1981, Immunostimulating substances from human casein, J Immunopharmacol, 3, 363, 10.3109/08923978109031067 · DOI · Paper page
  16. Yoshikawa, 1993, Immunostimulating peptide derived from soybean protein, Ann NY Acad Sci, 685, 375, 10.1111/j.1749-6632.1993.tb35892.x · DOI
  17. Fukudome, 1995, Effect of gluten exorphins A5 and B5 on the postprandial plasma insulin level in conscious rats, Life Sci, 57, 729, 10.1016/0024-3205(95)00324-Y · DOI
  18. Spruijt, 1992, Ethology and neurobiology of grooming behavior, Physiol Rev, 72, 825, 10.1152/physrev.1992.72.3.825 · DOI · Paper page
  19. Haley, 1957, Pharmacological effects produced by intra-cerebral injection of drugs in the conscious mouse, Br J Pharmacol, 12, 12
  20. Takagi, 1966, A modification of Haffner’s method for testing analgesics, Jpn J Pharmacol, 16, 287, 10.1254/jjp.16.287 · DOI · Paper page
  21. Izumi, 1983, Involvement of different mechanisms, opioid and non-opioid forms, in the analgesia induced by footshock (FS) and immobilized-water immersion (IW) stress, Jpn J Pharmacol, 33, 1104, 10.1254/jjp.33.1104 · doi:10.1254/jjp.33.1104
  22. Takahashi, 1987, Implication of endogenous opioid mechanism in the production of antinociceptive effect induced by psychological stress in mice, Jpn J Pharmacol, 44, 283, 10.1254/jjp.44.283 · DOI
  23. Ogawa, 1966, Psychophysiology of emotion - communication of emotion, Seishinshintaiigaku, 6, 352
  24. Lister, 1987, The use of a plus-maze to measure anxiety in the mouse, Psychopharmacology (Berl), 92, 180, 10.1007/BF00177912 · DOI · Paper page
  25. Shiigi, 1990, Facilitation of memory retrieval by pretest morphine mediated by μ but not δ and κ opioid receptors, Psychophamacology (Berl), 102, 329, 10.1007/BF02244099 · DOI
  26. Nishimura, 1990, State dependent and/or direct memory retrieval by morphine in mice, Psychopharmacology (Berl), 100, 27, 10.1007/BF02245784 · DOI
  27. Chang, 1982, Analgesic activity of intracerebroventricular administration of morphiceptin and β-casomorphins: correlation with the morphine (μ) receptor binding affinity, Life Sci, 30, 1547, 10.1016/0024-3205(82)90242-9 · DOI
  28. Fukudome, 1992, Opioid peptides derived from wheat gluten: their isolation and characterization, FEBS Lett, 296, 107, 10.1016/0014-5793(92)80414-C · DOI · Paper page
  29. Takahashi, 1988, Distinctive implication of emotional factors in various types of stress-induced analgesia, Jpn J Pharmacol, 46, 418, 10.1254/jjp.46.418 · DOI
  30. Tokuyama, 1989, Blockade of the development of analgesic tolerance to morphine by psychological stress through benzodiazepine receptor mediated mechanism, Jpn J Pharmacol, 51, 425, 10.1254/jjp.51.425 · doi:10.1254/jjp.51.425
  31. Feldberg, 1977, C-fragment of lipotropin - an endogenous potent analgesic peptide, Br J Phamacol, 60, 445, 10.1111/j.1476-5381.1977.tb07521.x · DOI
  32. Brantl, 1981, Opioid activities of β-casomorphins, Life Sci, 28, 1903, 10.1016/0024-3205(81)90297-6 · DOI · Paper page

Cited by

See all 75

Metadata

Authors
Takahashi, M., Fukunaga, H., Kaneto, H., Fukudome, S.-I., & Yoshikawa, M.
Venue
Japanese Journal of Pharmacology
Publisher
Elsevier BV
Published
2000
Volume
84
Issue
3
Pages
259-265
ISSN
0021-5198 (ISSN-L)
OpenAlex
W2022871517
Cited by
75
References
2
FWCI
0.74
Type
journal article
Language
en
Open access
diamond
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.